Beyond Prevalence: The Importance of Multifactorial Assessment in Cancer Risk Among Myotonic Dystrophy Patients

Documenti analoghi

• Reply to: “Beyond Prevalence: The Importance of Multifactorial Assessment in Cancer Risk Among Myotonic Dystrophy Patients”
  di: Wanfang Zhang, et al.
  Pubblicazione: (2025)
• Elevated Cancer Prevalence Identified at Specific Anatomical Sites Among People With Myotonic Dystrophy Using a Population‐Based Sample
  di: Wanfang Zhang, et al.
  Pubblicazione: (2025)
• Broadening the Comorbidity Landscape in Facioscapulohumeral Dystrophy: Beyond the Usual Suspects
  di: Christian Messina
  Pubblicazione: (2025)
• Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1
  di: Valeria A. Sansone, et al.
  Pubblicazione: (2026)
• Comparison of Two Questionnaires for Sleep‐Related Symptoms in Pediatric and Adult Patients With Myotonic Dystrophy Type 1
  di: Eleonora Silvana D'Ambrosio, et al.
  Pubblicazione: (2025)